The PDE6A gene helps rod cells in the retina turn light into signals your brain can use. This gene plays an important role in seeing in dim light, and if it does not work properly, those cells can gradually stop working and break down. Certain inherited variants in the PDE6A gene are linked to retinitis pigmentosa. People may first notice night blindness and a smaller field of side vision. Over time, vision loss can become more widespread.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for making proteins, the parts of cells that do much of the work. Others mainly help determine when certain processes happen, where they happen, and how strongly they are carried out. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. To explore this topic more deeply, you can read more in the LearnHub.
Overview
PDE6AGene function
What if the gene works
The PDE6A gene helps rod cells in the retina respond to low light. Its protein helps turn light into electrical signals by lowering cyclic GMP, a small messenger that controls channels in these cells.
Risk
What if the gene does not work
Variants in the PDE6A gene most often cause an inherited retinal condition, especially retinitis pigmentosa. People may first notice night blindness and narrowed side vision, with age of onset and severity varying from milder to more severe variants.
Treatment
What does that mean for your treatment
A pathogenic or loss-of-function variant in the PDE6A gene does not currently have an established treatment or management approach tied specifically to PDE6A in clinical guidelines. The PDE6A gene is being studied as a gene therapy target for inherited retinal conditions in preclinical and early stage research.
Conditions associated with PDE6A
Gene function
What if the gene works
In the retina, the PDE6A gene helps rod cells respond to dim light. Its protein forms part of an enzyme that lowers cyclic GMP, a small signal molecule, after light is detected. This change helps create the electrical message the brain uses for sight. It is a key part of how the PDE6A gene works in the retina to support night vision.
In rod cells, the PDE6A gene helps turn detected light into an internal message. Its protein is part of the enzyme that starts this step by lowering cyclic GMP, a signal molecule.
Lower cyclic GMP changes whether tiny channels in the rod cell membrane stay open or closed. This lets the cell shift its electrical activity and pass a visual signal forward.
Rod cells are the main light sensing cells used in dim settings, such as dusk or a dark room. By supporting normal rod signaling, the PDE6A gene helps your eyes handle low-light vision.
The PDE6A gene helps shape how long the rod cell light response lasts. This supports a controlled signal as lighting changes from moment to moment.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help explain normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the PDE6A gene can leave this retinal protein shortened, unstable, or much less active, so rod cells cannot keep cGMP, a signaling molecule, at the right level. Many PDE6A gene variants reduce function only partly, while more severe variants may stop the protein from being made at all. This range of effects can influence how much rod cell damage builds up and may relate to earlier or more pronounced retinitis pigmentosa.
How variants are linked to conditions
Pathogenic variants in the PDE6A gene cause autosomal recessive retinitis pigmentosa, an inherited eye condition that often starts with trouble seeing in dim light and gradually affects side vision. In some people, PDE6A-related retinitis pigmentosa begins in childhood, while others notice changes later. This is a confirmed gene-condition link, but symptoms and the pace of vision change can vary from person to person.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and instead reflect the natural diversity seen among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences also play a role. In other situations, one well understood variant in a particular gene is enough to establish the diagnosis.
Are there things that can increase or change my risk?
For PDE6A, risk is mainly shaped by inheritance rather than lifestyle. People usually develop related vision loss only if they inherit two nonworking copies of the PDE6A gene, so family history and whether both parents carry a changed copy matter most. There is not enough evidence to say that diet, exercise, or other everyday habits change the chance of developing it.
Inheritance of PDE6A variants
PDE6A-related conditions are usually inherited in an autosomal recessive pattern. This means a person typically inherits one PDE6A variant from each parent, and the parents are often healthy carriers who each have one changed copy of the PDE6A gene. When both parents are carriers, each pregnancy has a 25% chance of the child inheriting both variants, a 50% chance of being a carrier, and a 25% chance of inheriting neither variant. In practical terms, the PDE6A inheritance pattern usually affects siblings rather than passing directly from an affected parent to every child.
What does my PDE6A result mean for my family?
For PDE6A, family implications are usually those of a recessive inherited eye condition linked to retinitis pigmentosa. Brothers and sisters may also have the condition or be healthy carriers, and parents are often carriers without symptoms. Children of someone with a PDE6A-related condition will usually be carriers, and they are more likely to be affected only if the other parent also carries a changed PDE6A copy.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the PDE6A gene, doctors use genetic testing for PDE6A variants on a blood sample or cheek swab. A lab reads the gene’s DNA sequence and compares it with the usual sequence, which can confirm a variant linked to a condition, identify carrier status, or find a result that needs careful interpretation.
When should I consider getting a genetic test?
Genetic testing for the PDE6A gene may be worth considering if you or your child has signs of an inherited eye condition, such as night blindness, shrinking side vision, or retinitis pigmentosa. It can also help when similar vision loss runs in the family.
A genetic result is only one part of your health story
Genetic findings can provide meaningful insight, yet how much they reveal depends on the condition and on the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, these results can also help place individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can influence how your body handles certain medicines, including how they are absorbed, broken down, and how strongly they act. That helps explain why the same treatment may work well for one person, seem less effective for another, or cause more side effects in someone else. These differences are common and are one of several reasons medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect a person’s response to medications. It looks for links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body handles it. This information can support treatment decisions that are more informed and more individualized. To explore this subject in greater depth, you can learn more in the LearnHub.
Drugs influenced by the PDE6A gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how people respond to medicines, so any concerns about side effects, new symptoms, or whether a treatment is right for you are best discussed with your doctor.